|
1
|
Chomchai C and Chomchai S: Global patterns
of methamphetamine use. Curr Opin Psychiatr. 28:269–274. 2015.
View Article : Google Scholar
|
|
2
|
Mravčík V, Florián Z, Nečas V and Štolfa
J: Infectious and other somatic comorbidity in problem drug
users-results of a cross-sectional study with medical examination.
Epidemiol Mikrobiol Imunol. 65:56–62. 2016.(In Czech). PubMed/NCBI
|
|
3
|
Patel D, Desai GM, Frases S, Cordero RJ,
DeLeon-Rodriguez CM, Eugenin EA, Nosanchuk JD and Martinez LR:
Methamphetamine enhances Cryptococcus neoformans pulmonary
infection and dissemination to the brain. MBio. 4(pii): e00400–13.
2013.PubMed/NCBI
|
|
4
|
Peerzada H, Gandhi JA, Guimaraes AJ,
Nosanchuk JD and Martinez LR: Methamphetamine administration
modifies leukocyte proliferation and cytokine production in murine
tissues. Immunobiology. 218:1063–1068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arthur G and Bradding P: New developments
in mast cell biology: Clinical implications. Chest. 150:680–693.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamanishi Y and Karasuyama H: Basophils
and mast cells in immunity and inflammation. Semin Immunopathol.
38:535–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galli SJ, Kalesnikoff J, Grimbaldeston MA,
Piliponsky AM, Williams CM and Tsai M: Mast cells as ‘tunable’
effector and immunoregulatory cells: Recent advances. Annu Rev
Immunol. 23:749–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ryan JJ, Kashyap M, Bailey D, Kennedy S,
Speiran K, Brenzovich J, Barnstein B, Oskeritzian C and Gomez G:
Mast cell homeostasis: A fundamental aspect of allergic disease.
Crit Rev Immunol. 27:15–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galli SJ, Maurer M and Lantz CS: Mast
cells as sentinels of innate immunity. Curr Opin Immunol. 11:53–59.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marshall JS: Mast-cell responses to
pathogens. Nat Rev Immunol. 4:787–799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galli SJ, Nakae S and Tsai M: Mast cells
in the development of adaptive immune responses. Nat Immunol.
6:135–142. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abramson J and Pecht I: Regulation of the
mast cell response to the type 1 Fc epsilon receptor. Immunol Rev.
217:231–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Supajatura V, Ushio H, Nakao A, Akira S,
Okumura K, Ra C and Ogawa H: Differential responses of mast cell
Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin
Invest. 109:1351–1359. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sandig H and Bulfone-Paus S: TLR signaling
in mast cells: Common and unique features. Front Immunol.
3:1852012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leal-Berumen I, Conlon P and Marshall JS:
IL-6 production by rat peritoneal mast cells is not necessarily
preceded by histamine release and can be induced by bacterial
lipopolysaccharide. J Immunol. 152:5468–5476. 1994.PubMed/NCBI
|
|
16
|
Gupta AA, Leal-Berumen I, Croitoru K and
Marshall JS: Rat peritoneal mast cells produce IFN-gamma following
IL-12 treatment but not in response to IgE-mediated activation. J
Immunol. 157:2123–2128. 1996.PubMed/NCBI
|
|
17
|
Moiseeva EP and Bradding P: Mast cells in
lung inflammation. Adv Exp Med Biol. 716:235–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marinova T, Philipov S and Aloe L: Nerve
growth factor immunoreactivity of mast cells in acute involuted
human thymus. Inflammation. 30:38–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buchanan JB, Sparkman NL and Johnson RW: A
neurotoxic regimen of methamphetamine exacerbates the febrile and
neuroinflammatory response to a subsequent peripheral immune
stimulus. J Neuroinflammation. 7:822010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue L, Li X, Ren HX, Wu F, Li M, Wang B,
Chen FY, Cheng WY, Li JP, Chen YJ and Chen T: The dopamine D3
receptor regulates the effects of methamphetamine on LPS-induced
cytokine production in murine mast cells. Immunobiology.
220:744–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Najera JA, Bustamante EA, Bortell N,
Morsey B, Fox HS, Ravasi T and Marcondes MC: Methamphetamine abuse
affects gene expression in brain-derived microglia of SIV-infected
macaques to enhance inflammation and promote virus targets. BMC
Immunol. 17:72016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loftis JM: Commentary: Methamphetamine
mediates immune dysregulation in a murine model of chronic viral
infection. Front Microbiol. 6:14732015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abraham SN and St John AL: Mast
cell-orchestrated immunity to pathogens. Nat Rev Immunol.
10:440–452. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Galli SJ, Grimbaldeston M and Tsai M:
Immunomodulatory mast cells: Negative, as well as positive,
regulators of immunity. Nat Rev Immunol. 8:478–486. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stelekati E, Orinska Z and Bulfone-Paus S:
Mast cells in allergy: Innate instructors of adaptive responses.
Immunobiology. 212:505–519. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rao KN and Brown MA: Mast cells:
Multifaceted immune cells with diverse roles in health and disease.
Ann N Y Acad Sci. 1143:83–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gilfillan AM and Tkaczyk C: Integrated
signalling pathways for mast-cell activation. Nat Rev Immunol.
6:218–230. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kinet JP: The high-affinity IgE receptor
(Fc epsilon RI): From physiology to pathology. Annu Rev Immunol.
17:931–972. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rivera J and Gilfillan AM: Molecular
regulation of mast cell activation. J Allergy Clin Immunol.
117:1214–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dietrich N, Rohde M, Geffers R, Kröger A,
Hauser H, Weiss S and Gekara NO: Mast cells elicit proinflammatory
but not type I interferon responses upon activation of TLRs by
bacteria. Proc Natl Acad Sci USA. 107:pp. 8748–8753. 2010;
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takenaka H, Ushio H, Niyonsaba F,
Jayawardana ST, Hajime S, Ikeda S, Ogawa H and Okumura K:
Synergistic augmentation of inflammatory cytokine productions from
murine mast cells by monomeric IgE and toll-like receptor ligands.
Biochem Biophys Res Commun. 391:471–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Henz BM, Maurer M, Lippert U, Worm M and
Babina M: Mast cells as initiators of immunity and host defense.
Exp Dermatol. 10:1–10. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maurer M, Theoharides T, Granstein RD,
Bischoff SC, Bienenstock J, Henz B, Kovanen P, Piliponsky AM, Kambe
N, Vliagoftis H, et al: What is the physiological function of mast
cells? Exp Dermatol. 12:1–910. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maurer M and Metz M: The status quo and
quo vadis of mast cells. Exp Dermatol. 14:923–929. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sutherland RE, Olsen JS, McKinstry A,
Villalta SA and Wolters PJ: Mast cell IL-6 improves survival from
Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J
Immunol. 181:5598–5605. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Glocker EO, Kotlarz D, Klein C, Shah N and
Grimbacher B: IL-10 and IL-10 receptor defects in humans. Ann N Y
Acad Sci. 1246:102–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grimbaldeston MA, Nakae S, Kalesnikoff J,
Tsai M and Galli SJ: Mast cell-derived interleukin 10 limits skin
pathology in contact dermatitis and chronic irradiation with
ultraviolet B. Nat Immunol. 8:1095–1104. 2007. View Article : Google Scholar : PubMed/NCBI
|
